
Heidi L. Reese
Examiner (ID: 13855)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1657, 1625, 1622 |
| Total Applications | 1608 |
| Issued Applications | 1298 |
| Pending Applications | 5 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14018683
[patent_doc_number] => 20190071335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => HIGHLY EFFICIENT AEROBIC PHOSPHORUS-REMOVING BACTERIA CAPABLE OF SYNTHESIZING NANOPARTICLES BY MICROBIAL SELF-ASSEMBLY USING WASTE WATER
[patent_app_type] => utility
[patent_app_number] => 16/093639
[patent_app_country] => US
[patent_app_date] => 2017-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093639
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093639 | HIGHLY EFFICIENT AEROBIC PHOSPHORUS-REMOVING BACTERIA CAPABLE OF SYNTHESIZING NANOPARTICLES BY MICROBIAL SELF-ASSEMBLY USING WASTE WATER | Mar 1, 2017 | Abandoned |
Array
(
[id] => 13037319
[patent_doc_number] => 10040779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/446996
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32253
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446996
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/446996 | Histone demethylase inhibitors | Feb 28, 2017 | Issued |
Array
(
[id] => 14360013
[patent_doc_number] => 10301293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Amine-containing cyclic hydrofluoroethers and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/073849
[patent_app_country] => US
[patent_app_date] => 2017-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11245
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 362
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073849 | Amine-containing cyclic hydrofluoroethers and methods of using the same | Feb 27, 2017 | Issued |
Array
(
[id] => 12387714
[patent_doc_number] => 09963476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-08
[patent_title] => Antioxidant compound having anti atherosclerotic effect and preparation thereof
[patent_app_type] => utility
[patent_app_number] => 15/443538
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 32
[patent_no_of_words] => 5763
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443538
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443538 | Antioxidant compound having anti atherosclerotic effect and preparation thereof | Feb 26, 2017 | Issued |
Array
(
[id] => 16351810
[patent_doc_number] => 10792302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Composition for preventing or treating metabolism disorders comprising leuconostoc mesenteroides-producing exopolysaccharide as active ingredient
[patent_app_type] => utility
[patent_app_number] => 16/079498
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 6606
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079498 | Composition for preventing or treating metabolism disorders comprising leuconostoc mesenteroides-producing exopolysaccharide as active ingredient | Feb 23, 2017 | Issued |
Array
(
[id] => 11935211
[patent_doc_number] => 20170239361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'Compositions and Related Methods for the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 15/441191
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6705
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15441191
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/441191 | Compositions and related methods for the treatment of cancer | Feb 22, 2017 | Issued |
Array
(
[id] => 13931821
[patent_doc_number] => 20190049426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => CULTURING PATCH, CULTURING METHOD, CULTURE TEST METHOD, CULTURE TEST DEVICE, DRUG TEST METHOD, AND DRUG TEST DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/079299
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079299 | Culturing patch, culturing method, culture test method, culture test device, drug test method, and drug test device | Feb 22, 2017 | Issued |
Array
(
[id] => 13987283
[patent_doc_number] => 20190062799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => DETECTION OF BETA-HEMOLYTIC PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 16/079270
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079270
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/079270 | Detection of beta-hemolytic pathogens | Feb 22, 2017 | Issued |
Array
(
[id] => 11936388
[patent_doc_number] => 20170240537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'PRMT5 INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/438408
[patent_app_country] => US
[patent_app_date] => 2017-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36181
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15438408
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/438408 | PRMT5 INHIBITORS AND USES THEREOF | Feb 20, 2017 | Abandoned |
Array
(
[id] => 11668394
[patent_doc_number] => 20170157113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => '4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/435697
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14908
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15435697
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/435697 | 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor | Feb 16, 2017 | Issued |
Array
(
[id] => 16138929
[patent_doc_number] => 10702518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => TAF1 inhibitors for the therapy of cancer
[patent_app_type] => utility
[patent_app_number] => 16/077913
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 12
[patent_no_of_words] => 31192
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077913 | TAF1 inhibitors for the therapy of cancer | Feb 14, 2017 | Issued |
Array
(
[id] => 17045937
[patent_doc_number] => 11099109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Fixative
[patent_app_type] => utility
[patent_app_number] => 16/077269
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2184
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/077269 | Fixative | Feb 9, 2017 | Issued |
Array
(
[id] => 11662486
[patent_doc_number] => 20170151192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'METHODS, COMPOSITIONS AND DEVICES FOR TREATMENT OF MOTOR AND DEPRESSION SYMPTOMS ASSOCIATED WITH PARKINSON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/430305
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11138
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15430305
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/430305 | METHODS, COMPOSITIONS AND DEVICES FOR TREATMENT OF MOTOR AND DEPRESSION SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE | Feb 9, 2017 | Abandoned |
Array
(
[id] => 11649135
[patent_doc_number] => 20170145034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'ALKYNYL ALCOHOLS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/425698
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 124558
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/425698 | ALKYNYL ALCOHOLS AND METHODS OF USE | Feb 5, 2017 | Abandoned |
Array
(
[id] => 15541331
[patent_doc_number] => 10570432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Method for producing saccharified solution by enzymatic method using cellulose-type biomass as raw material
[patent_app_type] => utility
[patent_app_number] => 16/076629
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4318
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076629 | Method for producing saccharified solution by enzymatic method using cellulose-type biomass as raw material | Feb 2, 2017 | Issued |
Array
(
[id] => 14261247
[patent_doc_number] => 10280175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Hepatitis B antiviral agents
[patent_app_type] => utility
[patent_app_number] => 15/421777
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18916
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421777
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421777 | Hepatitis B antiviral agents | Jan 31, 2017 | Issued |
Array
(
[id] => 16640915
[patent_doc_number] => 10918736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Conjugate of therapeutic enzymes
[patent_app_type] => utility
[patent_app_number] => 16/073598
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17301
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073598
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073598 | Conjugate of therapeutic enzymes | Jan 30, 2017 | Issued |
Array
(
[id] => 14388311
[patent_doc_number] => 10307413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/419260
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56619
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15419260
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/419260 | Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof | Jan 29, 2017 | Issued |
Array
(
[id] => 13970391
[patent_doc_number] => 10214536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Amlexanox analogs
[patent_app_type] => utility
[patent_app_number] => 15/418244
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 49859
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15418244
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/418244 | Amlexanox analogs | Jan 26, 2017 | Issued |
Array
(
[id] => 16043235
[patent_doc_number] => 10683479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Whole stillage separation
[patent_app_type] => utility
[patent_app_number] => 15/417784
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 5387
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417784 | Whole stillage separation | Jan 26, 2017 | Issued |